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Research suggests the experimental manipulation of oxytocin facilitates positive 
interactions, cooperation and trust. The mechanism by which oxytocin influences social 
behavior is not well understood. We explored the hypothesis that oxytocin alters how 
people perceive themselves, which could be one mechanism by which oxytocin promotes 
prosocial behavior. In a between-subject, randomized, and double-blind experiment, 100 
university students received a 24 I.U. dose of intranasal oxytocin or placebo, and then 
completed the Revised NEO Personality Inventory (NEO-PI-R) and other self-report 
measures 90 minutes later. Intranasal oxytocin increased ratings of NEO-PI-R 
extraversion and openness to experiences (F(1,98) = 4.910, p = .025, partial η2 = .05; 
F(1,98) = 6.021, p = .016, partial η2 = .06), particularly for the following facets: positive 
emotions (d = 0.48, p < .05), warmth (d = 0.47, p < .05), openness to values (d = 0.45, p 
< .05) and ideas (d = 0.40, p < .05), trust (d = 0.44, p < .05) and altruism (d = 0.40, p < 
.05). Oxytocin had no influence on ratings of negative emotionality, conscientiousness, 
rejection sensitivity, depression, worry, self-esteem, and perceived social support. The 
administration of oxytocin improved participants’ self-perceptions of their personality, at 
least for certain traits important for social affiliation. Increased positive self-referential 
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Acute intranasal oxytocin improves positive self-perceptions of personality 
Introduction 
 The nonapeptide oxytocin is known for its role in reproduction and maternal 
behavior (Gimpl & Farenholz, 2001). In the last two decades, oxytocin has gained 
recognition for its effects on social behavior in animals (Carter, 1998; Insel, 2010). Since 
it was reported that the intranasal administration of neuropeptides increases their levels in 
cerebrospinal fluid (Born et al., 2002), there has been an upsurge of interest in 
experimental manipulations of central oxytocin in human populations (Bartz & 
Hollander, 2006; Campbell 2010; Heinrichs, von Dawans, & Domes, 2009). This body of 
research shows that oxytocin facilitates positive interactions (Ditzen et al., 2009; Naber, 
van Ijzendoorn, Deschamps, van Engeland, & Bakermans-Kranenburg, 2010), and 
improves cooperation, altruism, and trust in a variety of experimental contexts (Barraza, 
McCullough, Ahmadi, & Zak, 2011; Baumgartner, Heinrichs, Vonlanthen, Fischbacher, 
& Fehr,  2008; Declerck, Boone, & Kiyonari, 2010; Kosfeld, Heinrichs, Zak, 
Fischbacher, & Fehr, 2005; Mikolajczak et al., 2010a; Mikolajczak, Pinon, Lane, de 
Timary, & Luminet, 2010b).  
While the mechanism by which oxytocin facilitates prosocial behavior is 
unknown, a common view is that oxytocin alters how social signals in the external 
environment are processed, encoded, and/or interpreted (Bartz et al., 2010a; Ellenbogen, 
Linnen, Grumet, Cardoso, & Joober, 2012; Guastella, Mitchell, & Dadds, 2008; Marsh, 
Yu, Pine, & Blair, 2010; Theodoridou, Rowe, Penton-Voak, & Rogers, 2009). More 
recently, a hypothesis has been put forward that oxytocin alters cognition by increasing 





One advantage of this proposal is that it can explain why there are putative negative 
behavioral effects of oxytocin (Bartz et al., 2011b; De Dreu et al., 2010; De Dreu, Greer, 
Van Kleef, Shalvi, & Handgraaf, 2011; Shamay-Tsoory et al., 2009). The view that 
oxytocin increases attention to social cues is consistent with recent evidence showing that 
oxytocin influences the allocation of attentional resources to biological motion (Perry et 
al., 2010) and strengthens the orienting response to the eye region of the face—an effect 
that is associated with increased functional coupling of the basal amygdaloid nucleus and 
the superior colliculi (Gamer, Zurowski, & Büchel, 2010).  
Past research on intranasal oxytocin has focused primarily on how information in 
the external world is processed or interpreted (i.e. emotional faces, laboratory games, 
etc.). As an alternate or complimentary mechanism explaining the effect of oxytocin on 
social behavior, oxytocin may alter self-perceptions. That is, oxytocin may elicit changes 
in a person’s self-perceived altruistic, accepting, and socially-oriented traits, which in 
turn could promote affiliative behavior. There is some, albeit sparse, evidence consistent 
with this proposal. For example, acute intranasal oxytocin improves self-perceived 
coping style in humans (Cardoso, Linnen, Joober, & Ellenbogen, 2011) and attachment 
security in adult males (Buchheim et al., 2009). To further explore this hypothesis, we 
examined whether intranasal oxytocin influenced self-reported personality on the Revised 
NEO Personality Inventory (NEO-PI-R)— an instrument with excellent psychometric 
properties (Costa & McCrae, 1992) and temporal stability across 6 to 9 years (Costa, 
Herbst, McCrae, & Siegler, 2000). Considering that personality traits are deemed to be 
stable and enduring (Caspi, Roberts, & Shiner, 2005), this study represents an 





context of personality, the tendency to experience frequent positive emotions, and to 
evoke and enjoy social interactions characterizes extraversion, while agreeableness is 
characterized by prosocial tendencies like being empathetic, considerate, and helpful. 
Extraverted and agreeable children are more socially competent in their youth and later in 
adulthood, and these personality traits are associated with more positive responses from 
social partners (Asendorpf & van Aken, 2003; Caspi et al., 2005; Shiner, 2000). Thus, 
consistent with the prosocial literature on oxytocin, oxytocin-induced changes in self-
perception would likely target extraversion and agreeableness, rather than the other core 
personality factors such as neuroticism. 
We predicted that, relative to placebo, oxytocin would elicit higher self-report 
ratings of extraversion and agreeableness because these traits are deemed to promote 
social affiliation.  Because there are no studies in this area, we included all five factors of 
the NEO-PI-R in the data analyses. We also conducted exploratory analyses on the NEO-
PI-R facets (sub-scales) to follow up significant findings and to examine apriori 
predictions based on the literature (i.e. oxytocin influences trust).  To determine whether 
oxytocin alters core perceptions of the “social” self, via the assessment of personality 
traits, or whether it alters self-perceptions in general, we examined the influence of 
oxytocin and placebo on participants’ self-report of current depressive symptoms, trait 











 One hundred healthy university students (50 women) between the age of 18 and 
35 were recruited to participate in this study. Exclusion criteria included current 
medication use, presence of a medical illness or of a current or past mental disorder, 
lifetime recreational drug use (with the exception of cannabis, which required one-year 
abstinence and no history of use more than once every 6 months), smoking, pregnancy, 
and poor English language fluency. Exclusion criteria were assessed using an in-house 
structured interview protocol prior to participation. Participants were queried about 
current or past substance use, mental disorders, use of anti-depressants, anxiolytics, or 
any psychotropic medications and psychological treatments. For female participants, 
information regarding the menstrual cycle (date of last menses, average length of cycle) 
was collected. 
Forty-eight (24 women) and 52 (26 women) participants were randomized to an 
intranasal oxytocin and placebo condition, respectively. Participants randomized to the 
oxytocin and placebo condition were (mean ± SD) 22.4 ± 3.47 and 21.7 ± 3.35 years old, 
respectively. Four of 13 women in the follicular phase and 5 of 13 women in the luteal 
phase of their menstrual cycle were taking oral contraceptives in the placebo condition. 
Five of 13 women in the follicular phase and 2 of 11 women in the luteal phase of their 
menstrual cycle were taking oral contraceptives in the oxytocin condition. Statistical tests 
revealed that the following variables were balanced across drug condition: sex (t(98) = 0, 
p > .05), age (t(98) = -0.924, p > .05), menstrual phase (t(48) = 0.289, p > .05), and oral 





Research Ethics Committee at Concordia University (Montréal, Canada), and informed 
written consent was obtained from all participants.  
Measures 
The Revised NEO Personality Inventory (NEO-PI-R; Costa and McCrae 1992) 
consists of 240 items that define five factors of personality. High internal consistency has 
been reported for the NEO-PI-R, with coefficients ranging from .89 to .95 (Costa & 
McCrae, 1992), and temporal stability over six years (Costa et al. 2000; Herbst, McCrae, 
Costa, Feaganes, & Siegler). In the current sample, internal consistencies for the 
Neuroticism (α = .93), Extraversion (α = .90), Openness to experiences (α = .89), 
Agreeableness (α = .90), and Conscientiousness (α = .91) scales of the NEO-PI-R ranged 
from good to excellent. 
 The Interpersonal Support Evaluation List – College Version (ISEL; Cohen & 
Hoberman, 1983) is a 48-item inventory used to evaluate an individual’s perceived social 
support. The appraisal scale measures how comfortable an individual feels discussing 
their problems with people they know. The belonging scale measures an individual’s 
access to partners for social activities (e.g., people to go to the movies with). The self-
esteem scale measures how positively an individual compares themselves to people they 
know. The tangible scale measures an individual’s access to material resources (e.g., 
people who can loan them money). Scores range from 0 to 12 on each scale, with higher 
scores reflecting stronger endorsement of each category. The internal consistency for the 
ISEL (α = .84) in the current sample was good. 
 The Rejection Sensitivity Questionnaire (RSQ; Downey & Feldman, 1996) is 





exchanges. Scores on this inventory range from 0 to 36, with higher scores reflecting 
greater sensitivity to social rejection. The internal consistency for the RSQ (α = .86) in 
the current sample was good. 
 The Beck Depression Inventory-II (BDI; Beck, Steer, & Brown, 1996) is a 21-
item inventory that measures depressive symptoms. Scores on this inventory range from 
0 to 63, with higher scores reflecting more depressive symptoms. The internal 
consistency for the BDI (α = .89) in the current sample was good. 
 The Rosenberg Self-Esteem Scale (RSE; Rosenberg, 1965) is a 10-item 
inventory that measures global self-esteem. Scores on this inventory range from 10 to 40, 
with greater scores reflecting higher global self-esteem. The internal consistency for the 
RSE (α = .90) in the current sample was excellent. 
 The Penn-State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & 
Borkovec, 1990) is a 16-item inventory that measures trait worry. Scores on this 
inventory range from 16 to 80, with greater scores reflecting higher trait worry. The 
internal consistency for the PSWQ (α = .94) in the current sample was excellent. 
The Goal Adjustment Questionnaire (GAQ; Wrosch, Scheier, Miller, Schulz, & 
Carver, 2003) is a 10-item inventory that measures ability to disengage and reengage 
goals. Scores on goal disengagement range from 4 to 20, with higher scores reflecting a 
greater ability to disengage from goal attainment. Scores on the goal reengagement scale 
range from 6 to 30, with higher scores reflecting a greater ability to reengage goals. 
Internal consistencies for the goal disengagement (α = .86) and goal reengagement scales 







Participants self-administered a 24 I.U. dose of intranasal oxytocin (Syntocinon, 
Novartis, Basel, Switzerland) or a placebo (saline) 50 minutes prior to participating in the 
Yale Interpersonal Stressor, a standardized social rejection paradigm (Stroud, Tanofsky-
Kraff, Wilfley, & Salovey, 2000; Stroud, Salovey, & Epel, 2002). The stressor consisted 
of two staged conversations among three students (two of them being confederates), 
where the participant was increasingly excluded over time from the conversation. 
Findings associated with the stress manipulation are reported elsewhere (Cardoso et al., 
2011; Linnen, Ellenbogen, Cardoso, & Joober, 2012). Both the participant and 
experimenter were blind to the content of the nasal spray. Participants’ mood was 
measured using the Profile of Mood States (McNair, Lorr, & Droppleman, 1988) 10 
minutes before drug administration, 50 minutes after drug administration, 65 minutes 
after drug administration (after the first staged conversation) and 80 minutes after drug 
administration (after the second staged conversation). Mood ratings did not differ 
between the oxytocin and placebo conditions at any time point, and at 80 minutes post-
drug administration, mood ratings (higher scores = more positive mood) were 136 ± 36 
and 139 ± 34 in the oxytocin and placebo groups, respectively (Linnen et al., 2012). At 
90 minutes post-administration, participants completed a battery of questionnaires. 
Participants were then debriefed and asked to rate (1) how bad they felt in response to the 
social rejection paradigm and (2) how stressful they perceived the interaction to be, 
which were rated on a 5 point likert scale ranging from 1 (not at all) to 5 (extremely). 







 Separate drug X sex multivariate analyses of variance (MANOVAs) were 
conducted on the five factors of personality on the NEO-PI-R, the 4 scales of the ISEL, 
and the 2 scales of the GAQ. Individual scales and relevant facets were subsequently 
probed with univariate tests to disambiguate statistically significant multivariate effects, 
or statistical trends. Separate drug X sex analyses of variance (ANOVAs) were conducted 
on the ISEL, RSQ, BDI-II, RSE, and PSWQ, all of which had single measures. Planned 
comparisons on facets of the agreeableness factor of the NEO-PI-R were conducted based 
on apriori predictions supported by the literature (e.g., oxytocin influences trust.) 
All statistically significant multivariate effects were explored for interactions with 
oral contraceptive use and menstrual cycle phase in females using multivariate analysis of 
covariance (MANCOVAs) to determine if additional univariate tests should be conducted 
to probe these interactions. Finally, we examined whether exposure to the interpersonal 
stressor prior to completing the battery of tests influenced the relation between oxytocin 
and the aforementioned outcome variables. To do this, we conducted t-tests to determine 
if changes in personality paralleled changes in participant ratings of their subjective stress 
and negative affect following social rejection. We also conducted mediation analysis 
using Sobel’s test (Sobel, 1982) to determine if the effects of oxytocin on the outcome 
variables were mediated by the ratings of subjective stress and negative affect. 
Results 
The effect of drug administration on personality 
We detected a statistical trend for the association between drug condition and 





between drug and sex following a Drug (placebo, oxytocin) X Sex MANOVA of the 
NEO-PI-R five factors (drug: Wilks’ λ=.896, F(5, 92) = 2.146, p = .067; sex: Wilks’ 
λ=.845, F(5, 92) = 3.383, p = .008; drugXsex: Wilks’ λ=.986, F(5, 92) = 0.270, p = .928). 
Women (116.70 ± 17.56) scored higher than men (106.64 ± 20.39) on the agreeableness 
factor of the NEO-PI-R (F(1, 98) = 7.032, p = .009, partial η2 = .07). No significant sex 
differences were found on the remaining scales of the NEO-PI-R (data not shown).   
Participants reported higher extraversion and openness to experiences following 
oxytocin administration (See Figure 1), but we did not detect a statistical association 
between drug condition and neuroticism, agreeableness, or conscientiousness 
(extraversion: F(1, 98) = 4.910, p = .025, partial η2 = .05; openness to experiences: F(1, 
98) = 6.021, p = .016, partial η2 = .06;  neuroticism F(1, 98) = 0.381, p = .539; 
agreeableness: F(1, 98) = 0.397, p = .530; conscientiousness: F(1, 98) = 0.001, p = .981). 
Oxytocin administration was associated with higher ratings of positive emotions 
(d = 0.48, p < .05) and warmth (d = 0.47, p < .05) on the extraversion scale, and openness 
to values (d = 0.45, p < .05) and ideas (d = 0.40, p < .05) on the openness to experience 
scale following planned comparisons on facets of the NEO-PI-R. Since the literature 
indicates that oxytocin augments prosocial behavior, we conducted additional analyses on 
facets of the agreeableness factor. Ratings of trust (d = 0.44, p < .05) and altruism (d = 
0.40, p < .05) were higher following oxytocin administration. Statistics describing the 
facets of the extraversion, openness to experiences, and agreeableness factors can be 
found in Table 1. 
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Figure 1. Total scores on the five personality scales of the Revised NEO Personality 
Inventory in participants who self-administered intranasal oxytocin (n=48) or a placebo 






Table 1. Descriptive statistics for subscales of the NEO-PI by drug condition. 
 
Note: N = 48a, N = 52b, * p < .05 
 
 Oxytocina Placebob 95% CI  
Cohen 

















































Openness to Fantasy (O1) 
Openness to Aesthetics (O2) 
Openness to Feelings (O3) 
Openness to Actions (O4) 
Openness to Ideas (O5)* 































































































Examining potential confounds: Oral contraceptives, menstrual phase, and the 
impact of the interpersonal stressor 
We investigated a possible confounding relation between oxytocin, personality, 
oral contraceptive use, and menstrual phase. We did not detect a statistical interaction 
between oral contraceptive use and drug condition, or between menstrual phase and drug 
condition on scores on the NEO-PI-R following a drug X oral contraceptive use (no, yes) 
MANCOVA, controlling for menstrual phase (follicular, luteal), and a drug X menstrual 
phase MANCOVA, controlling for oral contraceptive use (drugXcontraceptive use: 
Wilks’ λ=.960, F(5, 41) = 0.342, p = .884; drugXmenstrual phase: Wilks’ λ=.865, F(5, 
41) = 1.280, p = .291). For this reason, we did not conduct further univariate tests to 
probe these interactions. 
 
We investigated a possible confounding relation between oxytocin, personality, 
and social rejection (which preceded completion of the questionnaire battery). If such a 
relation existed, we anticipated that ratings of stress and negative affect would parallel 
changes in personality across drug condition, or mediate the relation between oxytocin 
and personality. Ratings of stress did not differ between those administered oxytocin 
(1.93 ± 0.98) and those administered placebo [2.14 ± 0.91; F(1, 96) = 1.135 , p = .289]. 
Ratings of negative affect (i.e. how bad did you feel?) did not differ between participants 
administered oxytocin (2.02 ± .96) and those administered placebo [2.19 ± 1.05; F(1,96) 
= 0.719, p = .399]. Further, the effect of oxytocin on personality was not mediated by 
stress or negative affect, respectively, using Sobel’s test of mediation (1982) 
[extraversion (z = -1.041, p = .297; z = -0.574, p = .566); openness to experiences (z = 





positive emotions (z = 0.771, p = .440; z = -0.397, p = .691); openness to ideas (z = 
0.182, p = .855; z = -0.573, p = .567); openness to values (z = 0.022, p = .983; z = 0.141 , 
p = .888); trust (z = -0.249, p = .803; z = -1.306, p = .191); altruism (z = 0.267, p = .790; 
z = 0.576, p = .565)].  In summary, we found no evidence that oral contraceptive use, 
phase of menstrual cycle, or stressor-related effects influenced the relation between 
oxytocin and personality. 
The effect of drug administration on clinical symptoms, social support, and other 
questionnaires 
Descriptive statistics for the measures to follow are presented in Table 2. We 
detected no statistical relation between drug condition and the four subscales of the ISEL 
(social support), a statistical trend for the effect of sex, and no interaction between drug  
condition and sex following a drug X sex MANOVA (drug: Wilks’ λ=.984, F(4, 93) = 
0.373, p = .827; sex: Wilks’ λ=.920, F(4, 93) = 2.018, p = .098; drugXsex Wilks’ λ=.986, 
F(4, 93) = 0.270, p = .928).  
We detected no statistical relation between drug condition and the two subscales 
of the GAQ (goal engagement), no effect of sex, and no interaction between drug 
condition and sex following a drug X sex MANOVA (drug: Wilks’ λ=.988, F(2, 95) = 
0.575, p = .565; sex: Wilks’ λ=.999, F(2, 95) = 0.062, p = .940; drugXsex: Wilks’ 
λ=.999, F(4, 93) = 0.040, p = .961). Women (46.02 ± 13.51) scored higher on the PSWQ 
(trait worry) than men [40.48 ± 12.91; F(1,96) = 4.240, p = .042, partial η2 = .04], and 
our analyses revealed an interaction between sex and drug condition on scores on the BDI 
(depressive symptoms), as well as a statistical trend for the interaction between sex and 





Table 2. Descriptive statistics for perceived social support, global self-esteem, depressive 
symptoms, trait worry, rejection sensitivity, and goal adjustment style. 








 Oxytocina Placebob 
Variable M SD M SD 
Interpersonal Support Evaluation List (ISEL) 
     Appraisal 
     Belonging 
     Self-Esteem 
     Tangible 
Rejection Sensitivity (RSQ) 
Rosenberg’s Self-Esteem (RSE) 
Beck Depression Inventory (BDI) 
Penn-State Worry (PSWQ) 
Goal Adjustment Questionnaire (GAQ) 
     Goal Disengagement 





















































on the RSE (global self-esteem) (BDI: drugXsex: F(1,96) = 4.581, p = .035; RSE: 
drugXsex: F(1,96) = 3.072, p = .083). Follow-up analyses revealed no statistically 
significant effect of drug on the RSE or BDI in men or women [RSE men:(t(48) = 1.05, p 
= .299; women: t(48) = -1.420, p = .242)], [BDI men: t(48) = -1.924, p = .063; women: 
t(48) = 1.185, p = .242).We did not detect a statistical relation between drug, sex, and the 
interaction between drug and sex with any other variable [RSQ (rejection sensitivity) 
drug: F(1,96) = 0.265, p = .608; sex: F(1,96) = 0.016, p = .898; drugXsex: F(1,96) = 
0.237, p = .627)], [BDI drug: F(1,96) = 0.098, p = .754; sex: F(1,96) = 0.018, p = .894), 
[RSE drug: F(1,96) = 0.094, p = .760; sex: F(1,96) = 0.173, p = .678], [PSWQ drug: 
F(1,96) = 0.261, p = .610; drugXsex: F(1,96) = 0.246, p = .621].  
 
Discussion 
 The results of the present experiment indicate that intranasal oxytocin changes 
how participants perceive and report self-referential information deemed to be enduring 
and stable. Participants who self-administered intranasal oxytocin reported higher ratings 
of extraversion and openness to experiences than participants administered a placebo. 
Specifically, personality traits characterized by positive emotions, warmth, trust, altruism, 
and openness to values and ideas were most sensitive to oxytocin administration.  
 The pattern of results was strikingly consistent with the experimental literature 
(Ditzen et al., 2009; Kosfeld et al., 2005; Marsh et al., 2010)— only scales related to 
social behavior were altered by the administration of intranasal oxytocin relative to a 
placebo, with the exception of openness to experiences. The effects of oxytocin on self-





perceived their trait negative emotionality, conscientiousness, rejection sensitivity, worry, 
self-esteem, symptoms of depression, or ability to disengage from thwarted goals. 
Moreover, oxytocin had no impact on participants’ perceptions of their external social 
environment, in that it had no measurable impact on any of the perceived social support 
sub-scales assessed. Importantly, these findings cannot be attributed to mood change or 
changes in the perceived stressfulness of the social rejection paradigm, which all study 
participants experienced prior to completing questionnaires. Neither the mood (Linnen et 
al., 2012) nor subjective stress ratings were influenced by intranasal oxytocin. This is 
consistent with other research that suggests oxytocin does not have an appreciable effect 
on self-reported emotional states (Alvares, Hickie, & Guastella, 2010; Kirsch et al. 2005; 
Kosfeld et al. 2005). These data suggest that oxytocin modulated self-perceived 
personality (i.e. core traits) without modulating how participants responded to social 
rejection (i.e. current emotional state).  
These present results warrant consideration in the broader context of the 
experimental work on oxytocin. Recent evidence suggests intranasal oxytocin has 
differential effects on social behavior depending on contextual factors (Bartz et al., 
2011). For example, intranasal oxytocin has been shown to improve altruism only for 
people perceived to be part of an individual’s group, and not for people perceived to be 
part of an out-group (De Dreu et al., 2010; De Dreu et al., 2011). Further, oxytocin did 
not improve social cooperation when social partners were perceived to be untrustworthy 
(Mikolajczak et al., 2010a), uncooperative (Declerck et al., 2010), or antagonistic 
(Shamay-Tsoory et al. 2009; but see Baumgartner et al. 2008 for an exception). Other 





characteristics of the individual (Andari et al. 2010; Bartz et al. 2010a; Bartz et al. 2011). 
Taken together, there is a need to better understand the context- and person-dependent 
effects of oxytocin on social behavior, which now include changes in self-perception. 
The findings have important implications regarding the influence of oxytocin on 
human social behavior. We contend that increased self-perception of positive trait 
characteristics in response to oxytocin is consistent with a frame of mind that is tailored 
to the acquisition of new social relationships. This may occur, in part, via three distinct 
changes in information processing: increased salience of social stimuli (Bartz et al., 2011; 
Gamer et al., 2010; Perry et al., 2010), facilitated processing of positive interpersonal 
stimuli in the environment (Marsh et al., 2010; Unkelbach et al., 2008) and increased 
positive self-referential processing. Changes in the processing of external positive social 
stimuli may enable approach behavior (i.e. identifying cues that signal potential social 
interactions), while changes in positive self-referential processing may facilitate and 
reinforce actual social interactions (i.e. promoting reciprocal and affiliative social 
behavior). In support of the latter contention, oxytocin improves self-perceived 
attachment security (Bucheim et al., 2009) and coping style (Cardoso et al., 2011). 
In contrast to the findings for extraversion, the effect of oxytocin on openness to 
experiences was unexpected. The factor is defined as the active seeking and appreciation 
of experiences for their own sake (Costa et al., 2005; Costa & McCrae, 1992), and could 
theoretically facilitate the development of new relationships. Alternatively, the effect of 
oxytocin on increasing openness to experiences may be associated with a recent finding 
that oxytocin, relative to placebo, increases suggestibility during hypnosis (referred to as 





and hypnotizeability are known to correlate (Glisky, Tataryn, Tobias, Kihlstrom, & 
McConkey, 1991). Thus, it is possible that oxytocin-induced changes in self-perceived 
openness to experiences parallel behavioral changes in suggestibility. Clearly, the relation 
between openness to experiences, oxytocin, and suggestibility warrants further 
investigation. 
A number of study limitations warrant consideration. In the current study, the 
battery of questionnaires was administered to participants after a social rejection 
paradigm. It is possible that the reported findings are the result of a combined effect of 
social rejection and the drug manipulation. For example, it could be argued that oxytocin 
“prevented” a stress-induced decline in extraversion and openness to experiences, as 
opposed to increasing self-report ratings of these personality factors. While we cannot 
definitively rule out this possibility, it is unlikely for at least two reasons. If oxytocin 
prevented a stress-induced decline in personality ratings, one would expect to see similar 
changes in ratings of mood and subjective stress, which are more sensitive to 
interpersonal stress than trait measures of personality. Participants’ ratings of negative 
mood (Linnen et al., 2012) and subjective stress did not differ between the oxytocin and 
placebo conditions. Mediation analyses further supported our contention: ratings of 
subjective stress failed to mediate the relation between drug administration and 
personality. In addition, participants’ scores on the NEO-PI-R were within the normal 
range, and were comparable to an age-matched sample that did not undergo an 
interpersonal stress challenge or drug administration. For example, 102 participants from 





stressor scored 114.03 on extraversion, whereas participants in the present sample during 
the placebo condition scored 114.31. 
 History of mental illness was assessed using self-report, and it is possible that some 
participants had undiagnosed mental disorders that could have been screened using a 
structured diagnostic interview. The placebo nasal spray contained saline solution but 
none of the pharmacologically inactive compounds found in the oxytocin spray. Thus, it 
is possible that the findings observed in the present study could be due to the effects of a 
non-active compound administered with oxytocin. The present findings should be 
interpreted in light of a number of methodological issues in the study of intranasal 
oxytocin in humans, including the absence of data on dose-response individual 
differences (i.e. absorption rates). Timing issues also warrant some consideration. While 
most studies examine the effects of oxytocin 45 minutes after administration (Ditzen et 
al., 2009; Kosfeld et al., 2005), there was a 90 minute delay between testing and drug 
administration in the present study. It is unlikely that the delay had any impact on the 
results, as previous research has shown that peptide concentrations in the cerebrospinal 
fluid remain relatively stable even 80 minutes after administration (Born et al., 2002). 
Further, we have reported effects of oxytocin on cognition that can still be detected at 85-
115 minutes post-administration (Ellenbogen et al., 2012). Finally, it should be noted that 
while we did not find an effect of menstrual cycle or contraceptive use in the current 
study, self-report methods are not entirely reliable, and more subtle hormonal interactions 
may only become evident with use of better measures (e.g., hormone assays). 
An important implication of this research is that hormones, which fluctuate abreast 





increases endogenous oxytocin (Diamond, 2004), can influence the self-reporting of 
purportedly stable and enduring traits. Further, these data provide one explanation of how 
contextual effects (DeLongis & Holzman, 2005) influence the reporting of traits. In 
summary, the present study builds on previous experimental work to show that intranasal 
oxytocin influences how people perceive themselves, which is pertinent to our 
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In conducting our analyses, we detected a statistically significant interaction between sex 
and drug condition on scores on the BDI (depressive symptoms) [F(1,96) = 4.581, p = 
.035]. Follow-up analyses with simple comparisons revealed that there was no 
statistically significant effect of drug condition on female BDI scores [t(48) = 1.185, p = 
.242]. However, men in the placebo condition reported lower BDI scores (5.32 ± 5.10) 
relative to participants who administered intranasal oxytocin (7.69 ± 8.02), but this effect 
fell short of conventional statistical significance [t(48) = -1.924, p = .063].  
Interpretation of this effect requires caution, since it did not meet criteria for 
conventional statistical significance. One possible hypothesis for this effect is that men, 
who typically underreport depressive symptoms (Addis, 2008), were more likely to report 
depressive symptoms they experienced over the last 2 weeks more accurately because 
they felt more trusting towards this experimenter, which is consistent with our own 
results and that of other research (Mikolajczak, 2010). In addition to improved trust in the 
experimenter, this effect could have been partly driven by improved recall of 
autobiographical memories for the last 2 weeks, which is consistent with experimental 
findings in our own laboratory (Cardoso et al., 2012). In short, participants may have 
been able to better remember episodes in the last 2 weeks where they experienced 
depressive symptoms, and also felt more inclined to disclose this information as a result 
of improved trust in the experimenter. Further research is needed to explore the 
possibility that oxytocin changes how men report depressive symptoms, and possibly 
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